Evidence map›Paper›PMID 29306584›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2018

Assembly of 809 whole mitochondrial genomes with clinical, imaging, and fluid biomarker phenotyping.

Perry G Ridge, Mark E Wadsworth, Justin B Miller, Andrew J Saykin, Robert C Green, Alzheimer's Disease Neuroimaging Initiative, John S K Kauwe

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Perry G RidgeDepartment of Biology, Brigham Young University, Provo, UT, USA.
Mark E WadsworthDepartment of Biology, Brigham Young University, Provo, UT, USA.
Justin B MillerDepartment of Biology, Brigham Young University, Provo, UT, USA.
Andrew J SaykinRadiology and Imaging Sciences, Medical and Molecular Genetics and the Indiana Alzheimer's Disease Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Robert C GreenDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Partners HealthCare Personalized Medicine, The Broad Institute and Harvard Medical School, Boston, MA, USA.
Alzheimer's Disease Neuroimaging Initiative
John S K KauweDepartment of Biology, Brigham Young University, Provo, UT, USA; Department of Neuroscience, Brigham Young University, Provo, UT, USA. Electronic address: kauwe@byu.edu.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
Integration of Whole Genome Sequencing into Clinical MedicineU01HG006500 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI GREEN, ROBERT C. · 2012 to 2016
$11.5M
Risk Evaluation and Education for Alzheimer's Disease (REVEAL IV)R01HG002213 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI GREEN, ROBERT C. · 1999 to 2012
$7.6M
Memory Circuitry in MCI and Early Alzheimer’s Disease Prodrome: Molecular DriversR01AG019771 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 2001 to 2021
$6.9M
Genome Sequence-Based Screening for Childhood Risk and Newborn IllnessU19HD077671 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI BEGGS, ALAN H., GREEN, ROBERT C. · 2013 to 2018
$6.1M
Impact of Disclosing Amyloid Imaging Results to Cognitively Normal IndividualsRF1AG047866 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI GREEN, ROBERT C., KARLAWISH, JASON H · 2015 to 2019
$6.0M
Epidemiology of Alzheimer’s disease resilience and risk pedigreesRF1AG054052 · NIA · BRIGHAM YOUNG UNIVERSITY · PI KAUWE, JOHN SAI KEONG · 2016 to 2020
$3.6M
Research Supplements to Promote Diversity in Health-Related ResearchR01AG042611 · NIA · BRIGHAM YOUNG UNIVERSITY · PI KAUWE, JOHN SAI KEONG · 2012 to 2017
$1.5M
Bioinformatics Strategies for Multidimensional Brain Imaging GeneticsR01LM011360 · NLM · INDIANA UNIVERSITY INDIANAPOLIS · PI MOORE, JASON H., SAYKIN, ANDREW J · 2012 to 2015
$1.4M
NHGRI NIH HHS R01 HG002213NHGRI NIH HHS U01 HG006500NIA NIH HHS P30 AG010133NIA NIH HHS R01 AG019771NIA NIH HHS R01 AG042611NIA NIH HHS RF1 AG047866NIA NIH HHS RF1 AG054052NIA NIH HHS U01 AG024904NIA NIH HHS U24 AG021886NICHD NIH HHS U19 HD077671NLM NIH HHS R01 LM011360
6 · The paper itself

Abstract

introductionMitochondrial genetics are an important but largely neglected area of research in Alzheimer's disease. A major impediment is the lack of data sets.

methodsWe used an innovative, rigorous approach, combining several existing tools with our own, to accurately assemble and call variants in 809 whole mitochondrial genomes.

resultsTo help address this impediment, we prepared a data set that consists of 809 complete and annotated mitochondrial genomes with samples from the Alzheimer's Disease Neuroimaging Initiative. These whole mitochondrial genomes include rich phenotyping, such as clinical, fluid biomarker, and imaging data, all of which is available through the Alzheimer's Disease Neuroimaging Initiative website. Genomes are cleaned, annotated, and prepared for analysis. DISCUSSION: These data provide an important resource for investigating the impact of mitochondrial genetic variation on risk for Alzheimer's disease and other phenotypes that have been measured in the Alzheimer's Disease Neuroimaging Initiative samples.

Indexed as

Genome, MitochondrialAgedAlzheimer DiseaseApolipoproteins EBiomarkersBrainFemaleGenetic VariationHaplotypesHigh-Throughput Nucleotide SequencingHumansMaleNeuroimagingPhenotypeApolipoproteins EBiomarkersADNIAlzheimer's diseaseMitochondrial geneticsNext-generation sequencingWhole mitochondrial genomes

Identifiers

PMID29306584
PMCPMC5961720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.